Indication
Endometrial Cancer Stage II
1 clinical trial
1 product
Clinical trial
Randomized Phase III Trial of Molecular Profile-based Versus Standard Recommendations for Adjuvant Therapy for Women With Early Stage Endometrioid AdenocarcinomaStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Chemoradiation therapy